DEK in the Synovium of Patients With Juvenile Idiopathic Arthritis Characterization of DEK Antibodies and Posttranslational Modification of the DEK Autoantigen

University of Michigan, Ann Arbor, MI 48109-5640, USA.
Arthritis & Rheumatology (Impact Factor: 7.76). 02/2011; 63(2):556-67. DOI: 10.1002/art.30138
Source: PubMed


DEK is a nuclear phosphoprotein and autoantigen in a subset of children with juvenile idiopathic arthritis (JIA). Autoantibodies to DEK are also found in a broad spectrum of disorders associated with abnormal immune activation. We previously demonstrated that DEK is secreted by macrophages, is released by apoptotic T cells, and attracts leukocytes. Since DEK has been identified in the synovial fluid (SF) of patients with JIA, this study was undertaken to investigate how DEK protein and/or autoantibodies may contribute to the pathogenesis of JIA.
DEK autoantibodies, immune complexes (ICs), and synovial macrophages were purified from the SF of patients with JIA. DEK autoantibodies and ICs were purified by affinity-column chromatography and analyzed by 2-dimensional gel electrophoresis, immunoblotting, and enzyme-linked immunosorbent assay. DEK in supernatants and exosomes was purified by serial centrifugation and immunoprecipitation with magnetic beads, and posttranslational modifications of DEK were identified by nano-liquid chromatography tandem mass spectrometry (nano-LC-MS/MS).
DEK autoantibodies and protein were found in the SF of patients with JIA. Secretion of DEK by synovial macrophages was observed both in a free form and via exosomes. DEK autoantibodies (IgG2) may activate the complement cascade, primarily recognize the C-terminal portion of DEK protein, and exhibit higher affinity for acetylated DEK. Consistent with these observations, DEK underwent acetylation on an unprecedented number of lysine residues, as demonstrated by nano-LC-MS/MS.
These results indicate that DEK can contribute directly to joint inflammation in JIA by generating ICs through high-affinity interaction between DEK and DEK autoantibodies, a process enhanced by acetylation of DEK in the inflamed joint.

Download full-text


Available from: Nirit Mor-Vaknin,
  • Source
    • "Although DEK predominately localizes in the nucleus under steadystate conditions, induced DNA damage, apoptosis and pro-inflammatory environments lead to its presence in the extracellular space, either through passive release in apoptosis by T-cells or active secretion from macrophages [14] [15] [16]. Extracellular DEK, in turn, gains novel functions, exhibiting chemo-attractant properties, resulting in the attraction of certain immune cells such as leukocytes of the immune system to the site of inflammation [15] [16]. It has been shown recently by the addition of exogenous recombinant DEK that it can also mediate functions of hematopoietic stem cells (HSC) by suppressing proliferation of hematopoietic progenitor cells (HPC) and enhancing engraftment of long term repopulating cells [17] [18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: DEK is important in regulating cellular processes including proliferation, differentiation and maintenance of stem cell phenotype. The translocation t(6;9) in Acute Myeloid Leukemia (AML), which fuses DEK with NUP214, confers a poor prognosis and a higher risk of relapse. The over-expression of DEK in AML has been reported, but different studies have shown diminished levels in pediatric and promyelocytic leukemias. This study has characterized DEK expression, in silico, using a large multi-center cohort of leukemic and normal control cases. Overall, DEK was under-expressed in AML compared to normal bone marrow (NBM). Studying specific subtypes of AML confirmed either no significant change or a significant reduction in DEK expression compared to NBM. Importantly, the similarity of DEK expression between AML and NBM was confirmed using immunohistochemistry analysis of tissue mircorarrays. In addition, stratification of AML patients based on median DEK expression levels indicated that DEK showed no effect on the overall survival of patients. DEK expression during normal hematopoiesis did reveal a relationship with specific cell types implicating a distinct function during myeloid differentiation. Whilst DEK may play a potential role in hematopoiesis, it remains to be established whether it is important for leukemagenesis, except when involved in the t(6;9) translocation.
    Blood Cells Molecules and Diseases 12/2014; 54(1). DOI:10.1016/j.bcmd.2014.07.009 · 2.65 Impact Factor
  • Source
    • "In addition, citrullinated proteins, known to be autoantigens in RA, were detected in exosomes purified from the synovial fluids of RA patients [62]. Similarly, the autoantigen nuclear protein DEK, which contributes directly to joint inflammation in juvenile arthritis (JA), is secreted in both a free form and an exosome-associated form in the synovial fluids of JA patients [63, 64]. Exosomes containing annexins, which promote pathological mineral formation and articular chondrocytes destruction, were found more in the articular cartilage in OA patients [65]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Rheumatoid arthritis (RA) is a chronic autoimmune disease and one of the leading causes of disability in the USA. Although certain biological therapies, including protein and antibodies targeting inflammatory factors such as the tumor necrosis factor, are effective in reducing symptoms of RA, these treatments do not reverse disease. Also, although novel gene therapy approaches have shown promise in preclinical and clinical studies to treat RA, it is still unclear whether gene therapy can be readily and safely applied to treat the large number of RA patients. Recently, nanosized, endocytic-derived membrane vesicles "exosomes" were demonstrated to function in cell-to-cell communication and to possess potent immunoregulatory properties. In particular, immunosuppressive DC-derived exosomes and blood plasma- or serum-derived exosomes have shown potent therapeutic effects in animal models of inflammatory and autoimmune disease including RA. This paper discusses the current knowledge on the production, efficacy, mechanism of action, and potential therapeutic use of immunosuppressive exosomes for arthritis therapy.
    International Journal of Rheumatology 03/2012; 2012(10):573528. DOI:10.1155/2012/573528
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Heterochromatin integrity is crucial for genome stability and regulation of gene expression, but the factors involved in mammalian heterochromatin biology are only incompletely understood. Here we identify the oncoprotein DEK, an abundant nuclear protein with a previously enigmatic in vivo function, as a Suppressor of Variegation [Su(var)] that is crucial to global heterochromatin integrity. We show that DEK interacts directly with Heterochromatin Protein 1 α (HP1α) and markedly enhances its binding to trimethylated H3K9 (H3K9me3), which is key for maintaining heterochromatic regions. Loss of Dek in Drosophila leads to a Su(var) phenotype and global reduction in heterochromatin. Thus, these findings show that DEK is a key factor in maintaining the balance between heterochromatin and euchromatin in vivo.
    Genes & development 04/2011; 25(7):673-8. DOI:10.1101/gad.2036411 · 10.80 Impact Factor
Show more